Extracellular matrix (ECM) remodelling is an emerging area of cancer biology. Proteoglycans such as versican are key ECM components implicated in cancer progression. ADAMTS metalloproteinases cleave proteoglycans and typically act as tumour suppressors. Additional layers of complexity due to alternate isoforms, non-enzymatic functions and cell context.